Related Experiment Video

Updated: May 8, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Targeting the K-Ras/PDEδ protein-protein interaction: the solution for Ras-driven cancers or just another therapeutic

Brendan Frett1, Yuanxiang Wang, Hong-Yu Li

  • 1Department of Pharmacology & Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721 (USA); BIO5 Oro Valley (BIO5OV), University of Arizona, 1580 E. Hanley Blvd, Oro Valley, AZ 85737 (USA).

Chemmedchem
|August 14, 2013
PubMed

Insights

Researchers have identified a novel strategy to inhibit Ras signaling by blocking the K-Ras/PDEδ protein interaction. This breakthrough offers a promising new avenue for cancer therapy development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Ras oncogenes are implicated in numerous cancers, posing a significant therapeutic challenge.
  • Directly targeting Ras proteins has historically proven difficult, limiting treatment options.

Purpose of the Study:

  • To explore a novel therapeutic strategy targeting the K-Ras/PDEδ protein-protein interaction.
  • To assess the potential for clinically relevant inhibition of Ras signaling.

Main Methods:

  • Investigated the K-Ras/PDEδ protein-protein interaction.
  • Evaluated methods to block this specific interaction.

Main Results:

  • Successfully identified a method to inhibit Ras signaling by targeting the K-Ras/PDEδ interaction.
  • Demonstrated potential for clinically relevant inhibition levels.

Conclusions:

  • Blocking the K-Ras/PDEδ protein-protein interaction represents a promising new approach for Ras-targeted cancer therapy.
  • Further research is warranted to fully evaluate the clinical potential of this strategy.
Keywords:
Rasanticancer agentsdrug resistanceprotein–protein interactionstargeted therapeutics

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...